Related Experiment Videos
Recombinant Listeria monocytogenes cancer vaccines
1Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA. yvonne@mail.med.upenn.edu
Current Opinion in Immunology
|October 1, 1996
Abstract:
Listeria monocytogenes has recently been exploited as a vector for targeting antigens to the immune system. In the past year it has been shown to be particularly effective as a tumor antigen vector. Here we set its potency as a cancer vaccine in the context of the type of immunity induced by this facultative intracellular bacterium.